Evidence map›Paper›PMID 39749346›Full record

ArticleFrontiers in immunology2024

Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga and 31 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors.

Fernando Rodríguez-Jorge *Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
José Ignacio Fernández-Velasco *Immunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Noelia VillarrubiaImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Julia Gracia-GilNeurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Eva FernándezNeurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Virginia Meca-LallanaNeurology Department, Hospital Universitario La Princesa, Madrid, Spain.
Carolina Díaz-PérezNeurology Department, Hospital Universitario La Princesa, Madrid, Spain.
Susana Sainz de la MazaImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Eva María PachecoNeurology Department, Hospital Universitario Juan Ramon Jimenez, Huelva, Spain.
Ana QuirogaNeurology Department, Hospital Universitario de Gerona Doctor Josep Trueta, Gerona, Spain.
Lluis Ramió-TorrentàNeurology Department, Hospital Universitario de Gerona Doctor Josep Trueta, Gerona, Spain.
Sergio Martínez-YélamosNeurology Department, Hospital Universitario de Bellvitge, Barcelona, Spain.
Laura BauNeurology Department, Hospital Universitario de Bellvitge, Barcelona, Spain.
Enric MonrealNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Ana López-RealNeurology Department, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain.
Alexander Rodero-RomeroImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Laura BorregaNeurology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Santiago DíazNeurology Department, Hospital Universitario Gran Canaria Doctor Negrín, Gran Canaria, Spain.
Pablo EguíaNeurology Department, Hospital Universitario Gran Canaria Doctor Negrín, Gran Canaria, Spain.
Mercedes EspiñoImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Juan Luis Chico-GarcíaNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Francisco Javier BarreroNeurology Department, Hospital Universitario Clínico San Cecilio Granada, Granada, Spain.
María Luisa Martínez-GinésNeurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
José Manuel García-DomínguezNeurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
Soraya De la FuenteNeurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Irene MorenoNeurology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Raquel Sainz-AmoNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
M Alba Mañé-MartínezNeurology Department, Hospital Universitario Joan XXII, Tarragona, Spain.
Ana CamineroNeurology Department, Complejo Asistencial de Ávila, Ávila, Spain.
Fernando Castellanos-PinedoNeurology Department, Hospital Virgen del Puerto, Cáceres, Spain.
Ana Gómez LópezNeurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Andrés Labiano-FontcubertaNeurology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Lucía AyusoNeurology Department, Hospital Universitario Principe de Asturias, Madrid, Spain.
Rossana AbreuNeurology Department, Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain.
Miguel Ángel HernándezNeurology Department, Hospital Universitario Nuestra Señora Candelaria, Tenerife, Spain.
José Meca-LallanaNeurology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Lorena Martín-AguilarNeurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Alfonso Muriel GarcíaBiostatistics Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Jaime MasjuanNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Lucienne Costa-FrossardNeurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Luisa María VillarImmunology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1480676.].

Indexed as

glial fibrillary acidic proteinmultiple sclerosisneurofilament light chainocrelizumabserum biomarkers

Identifiers

PMID39749346
PMCPMC11693882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.